New combinatorial targeted therapies before haploidentical bone marrow transplantation for AML could also help expand access to potential cures for underserved populations
<p>CTI BioPharma and Fred Hutch announce international research fellowship in blood cancers; Dr. Julie Overbaugh receives $2.5M NIDA grant for HIV research; Dr. Johnnie Orozco wins grant to develop less-toxic cancer treatment; Dr. Philip Greenberg named editor-in-chief of Cancer Immunology Research; CFO Randy Main receives AIRI lifetime achievement award</p>
Solid-tumor faculty retreat fuels immunotherapy and precision-oncology research; Dr. Johnnie Orozco selected to participate in American Society of Hematology faculty-development program